What is the Ideal Blood Pressure Goal for Patients with Stage III or Higher Chronic Kidney Disease?
- First Online:
- Cite this article as:
- Khouri, Y., Steigerwalt, S.P., Alsamara, M. et al. Curr Cardiol Rep (2011) 13: 492. doi:10.1007/s11886-011-0215-0
- 152 Downloads
Hypertension and chronic kidney disease (CKD) are public health problems well known to the national and international medical communities. Blood pressure (BP) control in patients with CKD stage III and IV plays a key factor in reducing cardiovascular risk and renal disease progression. We conducted a literature review of recent studies addressing BP targets and cardiorenal outcomes in patients with CKD. Multiple studies demonstrated cardiovascular benefits associated with greater BP reduction. Nevertheless, a U-shaped relationship between BP, cardiovascular events, and renal function was present. In patients with CKD stage III and IV, a BP less than 140/90 mm Hg appeared to be a reasonable target. Moreover, in patients with CKD and proteinuria of more than 1 g/day, a target systolic BP of 120 to 130 mm Hg and diastolic BP of 70 to 80 mm Hg yielded the greatest benefit while avoiding most of the adverse cardiovascular outcomes associated with lower levels of BP.
KeywordsChronic kidney diseaseHypertensionCardiovascular eventsStrokeRenal functionBlood pressure targets
Clinical Trial Acronyms
African American Study of Kidney Disease and Hypertension
Action to Control Cardiovascular Risk in Diabetes
Action in Diabetes and Vascular disease: Preterax and Diamicron-MR Controlled Evaluation
Conduit Artery Function Evaluation
Heart Outcomes Prevention Evaluation
Hypertension Optimal Treatment
International Verapamil-Trandolapril Study
Modification of Diet in Renal Disease
National Health and Nutrition Examination Survey
Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial
Perindopril Protection Against Recurrent Stroke Study
- PROVE IT-TIMI 22
Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22
Ramipril Efficacy in Nephropathy
Valsartan Antihypertensive Long-term Use Evaluation.